首页> 美国卫生研究院文献>Journal of Clinical Laboratory Analysis >Expression of CD4+CD25highCD127low/− regulatory T cells in transitional cell carcinoma patients and its significance
【2h】

Expression of CD4+CD25highCD127low/− regulatory T cells in transitional cell carcinoma patients and its significance

机译:CD4 + CD25highCD127low /-调节性T细胞在过渡细胞癌患者中的表达及其意义

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

To evaluate the expressions of CD4 CD25 CD127 regulatory T cells (Tregs) in peripheral blood from patients with transitional cell carcinoma (TCC) in urinary system, we investigated the proportion of Treg population in CD4 T from 93 patients with TCC, 38 with benign urinary diseases, and 37 healthy subjects by using flow cytometric analysis and analyzing different clinicopathologic characteristics and the changes before and after operation. We found that the proportion of Treg in peripheral blood from patients with TCC was significantly increased as compared with the othertwo groups. There was a strong correlation between the proportion of Treg and tumor recurrence, quantity, lymph node metastasis ( <0.01), as well as pathological stage; no correlation was found between the proportion of Treg and clinical TNM stage ( >0.05). The proportion of Treg was also different before and after operation ( <0.05). This suggest that CD4 CD25 CD127 regulatory T cells may be responsible for immune suppression in TCC patients. The resection of tumor can decrease the proportion of Treg in peripheral blood. J. Clin. Lab. Anal. 23:197–201, 2009. © 2009 Wiley‐Liss, Inc.
机译:为了评估泌尿系统中移行细胞癌(TCC)患者外周血中CD4 CD25 CD127调节性T细胞(Tregs)的表达,我们调查了93例TCC患者,38例良性泌尿患者中CD4T中Treg人群的比例。通过流式细胞仪分析并分析不同的临床病理特征以及手术前后的变化,对37位健康受试者进行了研究。我们发现,与其他两组相比,TCC患者外周血中Treg的比例显着增加。 Treg的比例与肿瘤的复发,数量,淋巴结转移(<0.01)以及病理分期之间有很强的相关性。在Treg的比例和临床TNM分期之间没有相关性(> 0.05)。手术前后Treg的比例也不同(<0.05)。这表明CD4 CD25 CD127调节性T细胞可能是TCC患者免疫抑制的原因。肿瘤切除可以降低外周血中Treg的比例。 J.临床实验室肛门2009年23:197–201。©2009 Wiley-Liss,Inc.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号